Ursprung des Netzwerks ersten Grades von Halvor Jaeger
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Akela Pharma, Inc.
 Akela Pharma, Inc. Pharmaceuticals: MajorHealth Technology Akela Pharma, Inc. operates as a drug development company, which develops and manufactures pharmaceutical formulations and drugs. The company operates as a specialty contract pharmaceutical formulation developer and clinical and commercial drug manufacturer for proprietary drug products through its wholly-owned subsidiary, PharmaForm LLC, a pharmaceutical intellectual property development company. It provides specialty contract services in the area of pharmaceutical dosage form development, preclinical, scale-up, clinical and commercial supply manufacturing, focusing on controlled release and bioavailability enhancement technologies, such as hot melt extrusion, spray drying and liquid filled capsules. Akela Pharma was founded on November 15, 1988 and is headquartered in Austin, TX.
6
| Extinct | Pharmaceuticals: Major | 6 |
Universität Ulm
2
| College/University | Other Consumer Services | 2 |
| Subsidiary | Pharmaceuticals: Major | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Halvor Jaeger
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
Domain Associates LLC
 Domain Associates LLC Investment ManagersFinance Domain Associates LLC (Domain Associates) is a venture capital firm founded in 1985. The firm is headquartered in Princeton, New Jersey. | Investment Managers | Consultant / Advisor | |
American Association of Pharmaceutical Scientists
 American Association of Pharmaceutical Scientists BiotechnologyHealth Technology The American Association of Pharmaceutical Scientists engages in research and development of pharmaceutical products. The private company is based in Arlington, VA. The company was founded by Leslie Z. Benet. | Biotechnology | Corporate Officer/Principal | |
| American Association of Colleges of Pharmacy | College/University | Corporate Officer/Principal | |
| Texas A&M University | College/University | Undergraduate Degree | |
Enavail LLC
 Enavail LLC Pharmaceuticals: OtherHealth Technology Enavail LLC produces bioactive peptides and compounds for clinical research. Its technology focuses on generating crystalline or amorphous forms of poorly water-soluble compounds, providing enhanced dissolution and bioavailability, and producing powder forms of labile proteins. The company was founded in 2009 and is headquartered in Austin, TX. | Pharmaceuticals: Other | Chief Tech/Sci/R&D Officer | |
| The University of Texas at Austin | College/University | Corporate Officer/Principal | |
Mercedes-Benz Mobility AG
 Mercedes-Benz Mobility AG Finance/Rental/LeasingFinance Daimler Financial Services AG provides leasing and financial services. It offers financial services by providing tailor-made leasing and financing solutions to promote the vehicle sales of the DaimlerChrysler group’s brands worldwide. The firm’s products are offered to financial services for dealerships, commercial fleet management, the procurement of automotive insurance solutions, banking services, and mobility services like car2go. The company is headquartered in Stuttgart, Germany. | Finance/Rental/Leasing | Human Resources Officer | |
| EFB European Section on Applied Biocatalysis | Corporate Officer/Principal | ||
| University of Montréal | College/University | Corporate Officer/Principal | |
Trimel Biopharma, Inc.
 Trimel Biopharma, Inc. BiotechnologyHealth Technology Part of Acerus Pharmaceuticals Corp., Trimel Biopharma, Inc. develops biopharmaceutical products. The company is based in Mississauga, Canada. | Biotechnology | Director/Board Member | |
| ACERUS PHARMACEUTICALS CORPORATION | Pharmaceuticals: Major | Founder | |
Oncolinea Pharmaceuticals, Inc.
 Oncolinea Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Oncolinea Pharmaceuticals, Inc. develops pharmaceutical products. The CEO of the American company is Eckard Weber. | Pharmaceuticals: Major | Chief Executive Officer | |
Transposon Therapeutics, Inc.
 Transposon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Transposon Therapeutics, Inc. provides pharmaceutical products. The company is headquartered in Westport, CT. | Pharmaceuticals: Major | Chief Executive Officer | |
| ADYNXX, INC. | Pharmaceuticals: Major | Director/Board Member | |
American Chemical Society
 American Chemical Society Miscellaneous Commercial ServicesCommercial Services American Chemical Society engages as a scientific society which supports scientific inquiry in the field of chemistry. The company was founded in 1876 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
The Controlled Release Society
 The Controlled Release Society Miscellaneous Commercial ServicesCommercial Services The Controlled Release Society is a private company that focuses on providing fundamental delivery research, development, regulatory science, and clinical translation. The company is based in St. Paul, MN. The company was founded by Agis Kydonieus. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| TOBIRA THERAPEUTICS INC | Pharmaceuticals: Major | Director/Board Member | |
| Aalto University School of Business | College/University | Masters Business Admin | |
| McGill University | College/University | Undergraduate Degree | |
Ernst & Young LLP (Canada)
 Ernst & Young LLP (Canada) Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP (Canada) engages in the provision of consulting, assurance, tax, and transaction services. The company is headquartered in Toronto, Canada. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Mirror Biologics Inc
 Mirror Biologics Inc BiotechnologyHealth Technology Mirror Biologics Inc manufactures immune modulatory vaccines and therapeutics. The company is based in Tampa, FL. The company was founded in 2019 by Michael Har-Noy. Michael Har-Noy has been the CEO since 2019. | Biotechnology | Director/Board Member | |
Leiras
 Leiras Pharmaceuticals: OtherHealth Technology Part of Bayer AG, Leiras is a Finnish company that specializes in medicinal chemicals and botanical products. The company is located in Finland. Leiras was acquired by Bayer Schering Pharma AG on July 01, 1996 for $262.11 million. | Pharmaceuticals: Other | Corporate Officer/Principal | |
| RELIEF THERAPEUTICS HOLDING SA | Pharmaceuticals: Major | Chief Operating Officer | |
| SAVARA INC. | Pharmaceuticals: Major | President | |
| University of Helsinki | College/University | Doctorate Degree | |
| Association De Pharmacie Galenique Industrielle | Corporate Officer/Principal | ||
| ENZON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| US Ethicals, Inc. | Corporate Officer/Principal | ||
| Rhone-Poulenc Rorer Central Research | Corporate Officer/Principal | ||
Perseus Holdings USA LLC
 Perseus Holdings USA LLC Electronics DistributorsDistribution Services Perseus Holdings USA LLC markets vaccine platform technology. The company is headquartered in Austin, TX. | Electronics Distributors | Director/Board Member | |
| Alyrxx, Inc. | Director/Board Member | ||
| Kolping kolleg | College/University | Undergraduate Degree | |
| Domain Antibacterial Acquisition Corp. | Founder | ||
BioVascular, Inc.
 BioVascular, Inc. Pharmaceuticals: MajorHealth Technology BioVascular, Inc. develops drugs and devices for control of intimal hyperplasia associated with vascular procedures. It is a integrated specialty cardiovascular therapeutic company, and to utilize corporate partnerships in markets that have complex marketing barriers and/or combination technologies. The company was founded by John H. Parrish and Paul F. Glidden in 2005 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
| Tramoxia Therapeutics, Inc. | Chief Executive Officer | ||
| Konova, Inc. | Founder | ||
Ascenta Therapeutics, Inc.
 Ascenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ascenta Therapeutics, Inc. engages in the discovery and development of medicines for cancer. Its core technology consists of agents designed to re-establish the natural program of apoptosis (cell death) in abnormal cancer cells. Its has three small molecule programs against distinct apoptosis targets: Bcl-2 (AT-101 – an oral pan-Bcl2 inhibitor), IAP (AT-406 – an oral multi-IAP inhibitor) and HDM2. The company was founded by Dajun Yang, Marc E. Lippman, and Shaomeng Wang on June 5, 2006 and is headquartered in Malvern, PA. | Pharmaceuticals: Major | Chief Executive Officer | |
Cytovia, Inc.
 Cytovia, Inc. Miscellaneous Commercial ServicesCommercial Services Cytovia, Inc. provides biomedical research services. The firm discovers and develops therapeutics and products to assist physicians in curing cancer and certain degenerative diseases. The company was founded by Daniel Teper and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Founder |
Statistik
International
| Vereinigte Staaten | 35 |
| Kanada | 7 |
| Finnland | 5 |
| Deutschland | 4 |
| Spanien | 2 |
Sektoral
| Health Technology | 26 |
| Consumer Services | 9 |
| Commercial Services | 6 |
| Finance | 3 |
| Health Services | 2 |
Operativ
| Director/Board Member | 36 |
| Corporate Officer/Principal | 22 |
| Chief Executive Officer | 17 |
| Chairman | 13 |
| Founder | 13 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Halvor Jaeger
- Unternehmensverbindungen
